Welcome to our dedicated page for ORMAT TECHNOLOGIES SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ORMAT TECHNOLOGIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ORMAT TECHNOLOGIES's regulatory disclosures and financial reporting.
ORMAT TECHNOLOGIES, INC. director David Granot reported a combination of equity award activity and share sales. He exercised 1,315 Stock Appreciation Rights at an exercise price of $67.54 per share when the market price was $73.84, which generated 112 net shares after 1,203 shares were disposed of to the issuer for tax withholding related to the exercise. On the same date, he then sold a total of 950 shares of common stock in multiple open-market transactions at prices between $72.99 and $73.84. Following these transactions, he directly owned 2,825 shares of Ormat common stock. This Form 4 amendment corrects an earlier filing that had omitted the SAR exercise and tax-related disposition and had misclassified 112 net shares as an open-market sale.
ORA filed a Rule 144 notice reporting a proposed sale of restricted common stock. The filing lists 1,766 shares of Common Stock to be sold as restricted stock, with $237,394.55 shown on the cover line and Morgan Stanley Smith Barney LLC named as the broker. The filing also records a prior sale of 1,753 shares on 05/20/2026 for $232,623.10.
ORA submitted a Form 144 notice reporting proposed sales of Common Stock through Morgan Stanley Smith Barney LLC. The filing lists three restricted-share lots dated 06/02/2023 (1,461 shares), 05/09/2024 (761 shares), and 05/08/2025 (858 shares).
The Form 144 identifies the broker-dealer and characterizes the securities as restricted stock; the notice documents intended sales rather than completed open-market trades.
ORMAT TECHNOLOGIES, INC. executive vice president Benyosef Ofer reported a combination of stock option–style exercises and share sales in company common stock. He exercised 1,101 Stock Appreciation Rights with an exercise price of $71.15 per share, which resulted in 499 shares of common stock being issued and 602 shares effectively returned to the issuer as part of the SAR settlement mechanics. On the same date, he sold 9,429 shares of common stock in open-market transactions at $131.02 per share under a pre-arranged Rule 10b5-1 trading plan, and after these transactions he no longer directly holds Ormat common stock.
Ormat Technologies director Stanley Stern sold shares in a routine open-market transaction. On May 15, 2026, he sold 577 shares of Ormat Technologies common stock at a price of $130.17 per share. After this sale, he directly holds 6,050 common shares, indicating he retains a substantial position despite the relatively small disposition.
Ormat Technologies’ Chief Financial Officer Assi Ginzburg reported a combination of option exercises and share sales in Common Stock. On May 14, 2026, he exercised 5,502 Stock Appreciation Rights at an exercise price of $71.15 per share, converting them into Common Stock. The filing states that only 2,559 shares of Common Stock were issued from this SAR exercise, based on the difference between the market value of $133.118 and the exercise price. The CFO then disposed of shares through an issuer-related transaction and open-market sales totaling 17,776 shares at weighted average prices of $133.118 and $135.019 per share, across price ranges from $133.02 to $135.265. Following these transactions, he directly holds 1,970 shares of Ormat Technologies Common Stock.
ORMAT TECHNOLOGIES, INC. director Byron G. Wong reported an open-market sale of common stock. On May 13, 2026, he sold 4,500 shares of Ormat common stock at $134.32 per share. After this transaction, Wong directly owned 5,925 shares of Ormat common stock, and no derivative positions were reported in this filing.
ORA filed a Form 144 proposing the sale of restricted common stock by an issuer-affiliated holder. The notice lists proposed disposals of 100 shares with an intended sale date of 05/08/2026 and 477 shares with an intended sale date of 05/08/2025. Timing and cash‑flow treatment are as stated in the filing.
ORA submitted a Form 144 notifying proposed sales of common stock and several equity award types by an affiliate via broker Morgan Stanley Smith Barney LLC. The notice lists a total identifier 17,776 and dollar figure $2,395,227.75, and references 61,451,752 on the cover with an exchange listing of NYSE as of 05/14/2026.
The filing itemizes planned dispositions of equity awards by grant date and type, including Restricted Stock grants (e.g., 1,675 shares dated 05/12/2022, 837 dated 05/12/2024, 4,336 dated 03/01/2026), Stock Appreciation Rights (2,559 dated 05/14/2026), and Performance Shares (6,611 dated 03/21/2026 and 694 dated 03/01/2026).